Assessing sample adequacy and clinical performance of self-collected and clinician-collected HPV specimens using internal control Ct values
Open Access
- 5 September 2025
- journal article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 181, 105869
Abstract
No abstract availableKeywords
Funding Information
- Karolinska Institutet
- Bill and Melinda Gates Foundation (INV-021790)
This publication has 13 references indexed in Scilit:
- Quality Assurance in Cervical Cancer Screening: Evaluation of Sample Adequacy in HPV DNA TestingJournal of Medical Virology, 2025
- Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal SwabsThe Journal of Molecular Diagnostics, 2024
- Evaluation of the applicability of internal controls on self-collected samples for high-risk human papillomavirus is neededBMC Women's Health, 2023
- Quality assurance in human papillomavirus testing for primary cervical screeningInternational Journal of Gynecological Cancer, 2023
- HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance QuestionsCancer Epidemiology, Biomarkers & Prevention, 2023
- The challenges of defining sample adequacy in an era of HPV based cervical screeningJournal of Clinical Virology, 2021
- Maximizing confidence in a negative result: Quantitative sample adequacy controlJournal of Infection and Public Health, 2020
- VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samplesJournal of Clinical Virology, 2018
- HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assuranceJournal of Clinical Virology, 2016
- European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary DocumentAnnals of Oncology, 2010